Arctic Bioscience AS (OSL:ABS)

Norway · Delayed Price · Currency is NOK

3.450

+0.050 (1.47%)

Apr 29, 2026, 10:47 AM CET

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
B2C	4.95M	4.28M	3.49M			-	-
B2C Growth	15.89%	22.34%	-			-	-
B2B	38.53M	29.47M	30.78M			-	-
B2B Growth	30.72%	-4.23%	-			-	-
Pharmaceuticals	-	-	-			30.04M	24.85M
Pharmaceuticals Growth	-	-	-			20.89%	35.32%
Total	43.48M	33.75M	34.27M			30.04M	24.85M
Total Growth	28.84%	-1.52%	-			20.89%	35.32%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Norway	6.89M	6.04M	4.96M			-	24.85M
Norway Growth	14.09%	21.73%	-			-	35.32%
Americas	5.47M	5.52M	7.62M			-	-
Americas Growth	-0.98%	-27.50%	-			-	-
Europe	18.55M	12.42M	8.50M			-	-
Europe Growth	49.38%	46.07%	-			-	-
APAC	12.57M	9.77M	13.19M			-	-
APAC Growth	28.71%	-25.95%	-			-	-
Total	43.48M	33.75M	34.27M			-	24.85M
Total Growth	28.84%	-1.52%	-			-	35.32%

Source: S&P Global Market Intelligence.